Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 237 clinical trials
Featured trial
Acne, psoriasis, atopic dermatitis

Acne, psoriasis, atopic dermatitis

  • 2016 views
  • 25 Mar, 2021
  • 1 location
Featured trial
Study of Ruxolitinib Cream in Children With Atopic Dermatitis

Open-label, BID application to all affected areas identified at BSLN for 4 weeks (maximum use trial (MUsT) period). The next 4 weeks (treatment extension period) will be applied BID to active lesions only for the next 4 weeks for a total treatment period of 8 weeks. Eligible participants will be …

  • 0 views
  • 21 Mar, 2022
  • 16 locations
Featured trial
A research study for people with moderate to severe atopic dermatitis.

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Subcutaneous Lirentelimab in Adult Subjects with Moderate-to-Severe Atopic Dermatitis

corticosteroids
crisaborole
topical corticosteroid
topical agents
  • 0 views
  • 11 Jul, 2022
  • 1 location
Featured trial
A 10-12 week study to evaluate an oral medication for itching related to eczema (atopic dermatitis).

A 10-12 week study to evaluate an oral medication for itching related to eczema (atopic dermatitis).

  • 570 views
  • 08 Nov, 2020
  • 1 location
Featured trial
INCB 18424-303: Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 1 (TRuE-AD1)

A Phase 3, randomized (2:2:1), double-blind, 8-week vehicle control efficacy and safety study of ruxolitinib followed by a randomized, double-blind, 44-week long term safety (LTS) extension period.  In the LTS period,  participants initially randomized to vehicle will receive either ruxolitinib 0.75% or 1.5% cream.  All participants will have follow-up assessments …

eczema
atopic dermatitis
atopic dermatitis/eczema
  • 582 views
  • 10 May, 2022
  • 19 locations
Featured trial
Eczema Research Study - Compensation up to $420

  If you have symptoms of eczema such as itchy red patches you may qualify for a Research Study. Qualified participants receive study-related exams, medication and care from a

  • 243 views
  • 23 Nov, 2020
  • 1 location
Featured trial
INCB 18424-304: Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 2 (TRuE-AD2) for 304

A Phase 3, randomized (2:2:1), double-blind, 8-week vehicle control efficacy and safety study of ruxolitinib followed by a randomized, double-blind, 44-week long term safety (LTS) extension period.  In the LTS period,  participants initially randomized to vehicle will receive either ruxolitinib 0.75% or 1.5% cream.  All participants will have follow-up assessments …

eczema
atopic dermatitis
atopic dermatitis/eczema
dermatitis
  • 423 views
  • 03 May, 2022
  • 11 locations
Featured trial
We are currently recruiting participants for the BLUEPRINT study. This study investigates the effectiveness, safety, and tolerability of the drug BLU-5937 for chronic itch in people with eczema.

eczema and overall health will be done with the study team. 

dermatitis
adult atopic dermatitis
atopic dermatitis/eczema
atopic dermatitis
eczema
  • 82 views
  • 10 Dec, 2020
  • 25 locations
Featured trial
A 3-week study to evaluate a generic non-steroidal topical cream for the treatment of eczema.

A 3-week study to evaluate a generic non-steroidal topical cream for the treatment of eczema.

  • 190 views
  • 08 Nov, 2020
  • 1 location
Featured trial
A 4-week study to evaluate a generic non-steroidal topical cream for the treatment of eczema.

A 4-week study to evaluate a generic non-steroidal topical cream for the treatment of eczema.

  • 109 views
  • 08 Nov, 2020
  • 1 location